<?xml version="1.0" encoding="UTF-8"?>
<ref id="b49-dic-2020-4-15">
 <label>49</label>
 <element-citation publication-type="webpage">
  <collab>Gilead Science</collab>
  <source>Gilead announces results from phase 3 trial of investigational antiviral remdesivir in patients with severe COVID-19</source>
  <comment>
   <ext-link ext-link-type="uri" xlink:href="https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19</ext-link>. Published 2020
  </comment>
  <date-in-citation>Accessed May 27, 2020</date-in-citation>
 </element-citation>
</ref>
